Adalimumab in Patients with Active Noninfectious Uveitis
Glenn J. Jaffe(The University of Texas Health Science Center at San Antonio), Eric B. Suhler(National Institute for Health Research)
Cited by 646
Related Papers
Ranibizumab and Bevacizumab for Treatment of Neovascular Age-related Macular Degeneration
|Ophthalmology|2012|1.7k
Five-Year Outcomes with Anti–Vascular Endothelial Growth Factor Treatment of Neovascular Age-Related Macular Degeneration
|Ophthalmology|2016|702
Risk of Geographic Atrophy in the Comparison of Age-related Macular Degeneration Treatments Trials
|Ophthalmology|2013|585
Risk of Scar in the Comparison of Age-related Macular Degeneration Treatments Trials
|Ophthalmology|2013|325